• Molecular NameLornoxicam
  • SynonymAcabel; chlortenoxicam; CLTX; CTX; Lorcam; Lorcam (TN); Lornoxicamum; Lornoxicamum [inn-latin]; Safem; Taigalor; Telos; XEFO; Xefocam
  • Weight371.825
  • Drugbank_IDN/A
  • ACS_NO70374-39-9
  • Show 2D model
  • LogP (experiment)2.62
  • LogP (predicted, AB/LogP v2.0)2.36
  • pkaN/A
  • LogD (pH=7, predicted)0.69
  • Solubility (experiment)N/A
  • LogS (predicted, ACD/Labs)(ph=7)-1.29
  • LogSw (predicted, AB/LogsW2.0)0.03
  • Sw (mg/ml) (predicted, ACD/Labs)0.11
  • No.of HBond Donors2
  • No.of HBond Acceptors7
  • No.of Rotatable Bonds2
  • TPSA136.22
  • StatusN/A
  • AdministrationN/A
  • PharmacologyN/A
  • Absorption_value100.0
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein bindingN/A
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmA non-steroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties. It is available in oral and parenteral formulations.
  • Half lifeOxidized by CYP2C9 to the 5'-hydroxy metabolite in the liver.
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A